ADHD :: FDA approval of Vyvanse as a novel treatment for ADHD

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Nurse :: Mobile clinical assistant MCA for nurses

Intel Corporation announced the mobile clinical assistant (MCA) is ready to enable nurses to spend more time with patients, do their jobs on the move while remaining connected, and manage the administration of medications.

Stroke :: Learning to prevent medical mistakes in caring for stroke patients

Medical errors and adverse events can happen in patients with stroke, and hospital procedures need to be modified to reduce the likelihood of error and patients getting hurt, according to a study published in the February 20, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.

Transplant :: Teens may lose transplanted organs when insurance runs out

A new study shows that young transplant patients in the US who lose their insurance coverage are more likely to stop taking necessary anti-rejection drugs, which can increase the risk of losing the transplanted organs. The study appears in the latest issue of Pediatric Transplantation.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack